APPLICATION
ANDA206198
TYPE
ANDA
ORIGINAL APPROVAL
2020-07-20
LATEST ACTION
2020-07-20
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
OXACILLIN SODIUMPrescription
OXACILLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
OXACILLIN SODIUMPrescription
OXACILLIN SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-07-20UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.